Understanding drug-related side effects in breast cancer treatment
Official title: Analyzing Patient-Level Data in a Breast Cancer Clinical Trial
Funded at University of California, San Francisco · NIH-10890574 · Data updated 2026-11-12
This study is looking at how women being treated for breast cancer experience side effects, like tiredness and nerve pain, to help improve communication with their doctors and find ways to make those side effects easier to manage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | July 19, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $350,960 |
| NIH project number | 5R01CA283179-02 |
| Project ID | NIH-10890574 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women diagnosed with high-risk, early-stage breast cancer who are undergoing treatment.
✕Less likely to help
Patients who are not currently receiving treatment for breast cancer or those with late-stage breast cancer may not benefit from this research.
What this research studies
This research focuses on analyzing patient-level data from a clinical trial to better understand the side effects experienced by women undergoing treatment for breast cancer. By utilizing an electronic patient-reported outcomes platform, the study aims to collect and assess information on adverse events and quality of life in real time. This approach seeks to improve the recognition of drug-related toxicities, such as fatigue and neuropathy, which are often underreported. The goal is to enhance communication between patients and healthcare providers, leading to timely interventions that can mitigate serious side effects.
Why it matters
Potential benefit: If successful, this research could lead to improved management of side effects in breast cancer treatments, enhancing patients' quality of life.
How similar studies have gone: Other research has shown that patient-reported outcomes can significantly improve the management of treatment side effects, indicating a promising approach in this area.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Somani, Amrita Basu — University of California, San Francisco
- Study coordinator: Somani, Amrita Basu
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.